{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:48:43Z","timestamp":1787024923506,"version":"build-2736575974"},"reference-count":100,"publisher":"Japanese Association of Virology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2011]]},"DOI":"10.2222\/jsv.61.163","type":"journal-article","created":{"date-parts":[[2013,4,29]],"date-time":"2013-04-29T19:08:35Z","timestamp":1367262515000},"page":"163-174","source":"Crossref","is-referenced-by-count":4,"title":["Chronic Active Epstein-Barr Virus Infection"],"prefix":"10.2222","volume":"61","author":[{"given":"Hiroshi","family":"KIMURA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1062","reference":[{"key":"1","unstructured":"1) Rickinson AB, Kieff E. Epstein-Barr Virus and Its Replication. In: Knipe DM, Howly PM (eds). Virology, 5th edn, vol. 2. Wolters kluwer\/Lippincott Williams & Wilkins: Philadelphia, 2006, pp 2603-2654."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Cohen JI. Epstein-Barr virus infection. N Engl J Med 343(7): 481-492,2000","DOI":"10.1056\/NEJM200008173430707"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Kimura H. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency? Rev Med Virol 16(4): 251-261,2006","DOI":"10.1002\/rmv.505"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 98(2): 280-286.,2001","DOI":"10.1182\/blood.V98.2.280"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Kimura H, Hoshino Y, Hara S, Sugaya N, Kawada J, Shibata Y, Kojima S, Nagasaka T, Kuzushima K, Morishima T. Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection. J Infect Dis 191(4): 531-539,2005","DOI":"10.1086\/427239"},{"key":"6","unstructured":"6) Ohshima K, Kimura H, Yoshino T, Kim CW, Ko YH, Lee SS, Peh SC, Chan JK. Proposed categorization of pathological states of EBV-associated T\/natural killer-cell lymphoproliferative disorder (LPD) in children and young adults: overlap with chronic active EBV infection and infantile fulminant EBV T-LPD. Pathol Int 58(4): 209-217,2008"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 350(13): 1328-1337,2004","DOI":"10.1056\/NEJMra032015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol 81(15): 7825-7832,2007","DOI":"10.1128\/JVI.00445-07"},{"key":"9","unstructured":"9) Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol 25: 587-617, 2007"},{"key":"10","unstructured":"10) Rickinson AB, Kieff E. Epstein-Barr Virus. In: Knipe DM, Howly PM (eds). Virology, 5th edn, vol. 2. Wolters kluwer\/Lippincott Williams & Wilkins: Philadelphia, 2006, pp 2655-2700."},{"key":"11","unstructured":"11) Nakamura S, Jaffe ES, Swerdlow SH. EBV positive diffuse large B-cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. WHO Press: Lyon, 2008, pp 243-244."},{"key":"12","unstructured":"12) Williams H, Crawford DH. Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood 107(3): 862-869,2006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Fox CP, Shannon-Lowe C, Rowe M. Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations. Herpesviridae 2: 8,2011","DOI":"10.1186\/2042-4280-2-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Virelizier JL, Lenoir G, Griscelli C. Persistent Epstein-Barr virus infection in a child with hypergamma-globulinaemia and immunoblastic proliferation associated with a selective defect in immune interferon secretion. Lancet 2(8083): 231-234, 1978","DOI":"10.1016\/S0140-6736(78)91744-0"},{"key":"15","unstructured":"15) Tobi M, Straus SE. Chronic Epstein-Barr virus disease: a workshop held by the National Institute of Allergy and Infectious Diseases. Ann Intern Med 103(6 ( Pt 1)): 951-953,1985"},{"key":"16","unstructured":"16) Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med 102(1): 1-7,1985"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Straus SE, Tosato G, Armstrong G, Lawley T, Preble OT, Henle W, Davey R, Pearson G, Epstein J, Brus I, et al. Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Ann Intern Med 102(1): 7-16,1985","DOI":"10.7326\/0003-4819-102-1-7"},{"key":"18","unstructured":"18) Straus SE, Cohen JI, Tosato G, Meier J. NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann Intern Med 118(1): 45-58,1993"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Rickinson AB. Chronic, symptomatic Epstein-Barr virus infection. Immunology Today 7: 13-14,1986","DOI":"10.1016\/0167-5699(86)90183-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Straus SE. The chronic mononucleosis syndrome. J Infect Dis 157(3): 405-412,1988","DOI":"10.1093\/infdis\/157.3.405"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Okano M, Matsumoto S, Osato T, Sakiyama Y, Thiele GM, Purtilo DT. Severe chronic active Epstein-Barr virus infection syndrome. Clin Microbiol Rev 4(1): 129-135,1991","DOI":"10.1128\/CMR.4.1.129"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kikuta H, Taguchi Y, Tomizawa K, Kojima K, Kawamura N, Ishizaka A, Sakiyama Y, Matsumoto S, Imai S, Kinoshita T, et a. Epstein-Barr virus genome-positive T lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature 333(6172): 455-457,1988","DOI":"10.1038\/333455a0"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Jones J, Shurin S, Abramowsky C, Tubbs R, Sciotto C, Wahl R, Sands J, Gottman D, Katz B, Sklar J. T-cell lymphomas containing Epstein-Barr viral DNA in patients with chronic Epstein-Barr virus infections. N Engl J Med 318(12): 733-741,1988","DOI":"10.1056\/NEJM198803243181203"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84(1): 51-55,1989","DOI":"10.1172\/JCI114168"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Imai S, Sugiura M, Oikawa O, Koizumi S, Hirao M, Kimura H, Hayashibara H, Terai N, Tsutsumi H, Oda T, Chiba S, Osato T. Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood 87(4): 1446-1457,1996","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H. Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line. Clin Exp Immunol 115(3): 385-392,1999","DOI":"10.1046\/j.1365-2249.1999.00836.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Nagata H, Konno A, Kimura N, Zhang Y, Kimura M, Demachi A, Sekine T, Yamamoto K, Shimizu N. Characterization of novel natural killer (NK)-cell and gammadelta T-cell lines established from primary lesions of nasal T\/NK-cell lymphomas associated with the Epstein-Barr virus. Blood 97(3): 708-713,2001","DOI":"10.1182\/blood.V97.3.708"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Zhang Y, Nagata H, Ikeuchi T, Mukai H, Oyoshi MK, Demachi A, Morio T, Wakiguchi H, Kimura N, Shimizu N, Yamamoto K. Common cytological and cytogenetic features of Epstein-Barr virus (EBV)-positive natural killer (NK) cells and cell lines derived from patients with nasal T\/NK-cell lymphomas, chronic active EBV infection and hydroa vacciniforme-like eruptions. Br J Haematol 121(5): 805-814,2003","DOI":"10.1046\/j.1365-2141.2003.04359.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kawa K, Okamura T, Yagi K, Takeuchi M, Nakayama M, Inoue M. Mosquito allergy and Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease. Blood 98(10): 3173-3174.,2001","DOI":"10.1182\/blood.V98.10.3173"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kimura H, Morishima T, Kanegane H, Ohga S, Hoshino Y, Maeda A, Imai S, Okano M, Morio T, Yokota S, Tsuchiya S, Yachie A, Imashuku S, Kawa K, Wakiguchi H. Prognostic factors for chronic active Epstein-Barr virus infection. J Infect Dis 187(4): 527-533,2003","DOI":"10.1086\/367988"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Pachlopnik Schmid J, Canioni D, Moshous D, Touzot F, Mahlaoui N, Hauck F, Kanegane H, Lopez-Granados E, Mejstrikova E, Pellier I, Galicier L, Galambrun C, Barlogis V, Bordigoni P, Fourmaintraux A, Hamidou M, Dabadie A, Le Deist F, Haerynck F, Ouachee-Chardin M, Rohrlich P, Stephan JL, Lenoir C, Rigaud S, Lambert N, Milili M, Schiff C, Chapel H, Picard C, de Saint Basile G, Blanche S, Fischer A, Latour S. Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency). Blood 117(5): 1522-1529,2011","DOI":"10.1182\/blood-2010-07-298372"},{"key":"32","unstructured":"32) Gholam C, Grigoriadou S, Gilmour KC, Gaspar HB. Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management. Clin Exp Immunol 163(3): 271-283,2011"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Sumazaki R, Kanegane H, Osaki M, Fukushima T, Tsuchida M, Matsukura H, Shinozaki K, Kimura H, Matsui A, Miyawaki T. SH2D1A mutations in Japanese males with severe Epstein-Barr virus--associated illnesses. Blood 98(4): 1268-1270.,2001","DOI":"10.1182\/blood.V98.4.1268"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, Dale JK, Straus SE, Cohen JI. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 103(4): 1244-1252,2004","DOI":"10.1182\/blood-2003-06-2171"},{"key":"35","unstructured":"35) Cohen JI, Kimura H, Nakamura S, Ko YH, Jaffe ES. Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol 20(9): 1472-1482,2009"},{"key":"36","unstructured":"36) Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, Gottschalk S, Bollard CM, Rao VK, Marques A, Burbelo PD, Turk SP, Fulton R, Wayne AS, Little RF, Cairo MS, El-Mallawany NK, Fowler D, Sportes C, Bishop MR, Wilson W, Straus SE. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood 117(22): 5835-5849,2011"},{"key":"37","unstructured":"37) Arai A, Imadome K, Watanabe Y, Yoshimori M, Koyama T, Kawaguchi T, Nakaseko C, Fujiwara S, Miura O. Clinical features of adult-onset chronic active Epstein-Barr virus infection: a retrospective analysis. Int J Hematol 93(5): 602-609,2011"},{"key":"38","unstructured":"38) Alfieri C, Ghibu F, Joncas JH. Lytic, nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. Can Med Assoc J 131(10): 1249-1252,1984"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Shibata Y, Hoshino Y, Hara S, Yagasaki H, Kojima S, Nishiyama Y, Morishima T, Kimura H. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. J Med Virol 78(6): 770-779,2006","DOI":"10.1002\/jmv.20622"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Kubota N, Wada K, Ito Y, Shimoyama Y, Nakamura S, Nishiyama Y, Kimura H. One-step multiplex real-time PCR assay to analyse the latency patterns of Epstein-Barr virus infection. J Virol Methods 147: 26-36,2008","DOI":"10.1016\/j.jviromet.2007.08.012"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Iwata S, Wada K, Tobita S, Gotoh K, Ito Y, Demachi-Okamura A, Shimizu N, Nishiyama Y, Kimura H. Quantitative analysis of Epstein-Barr virus (EBV)-related gene expression in patients with chronic active EBV infection. J Gen Virol 91(Pt 1): 42-50,2010","DOI":"10.1099\/vir.0.013482-0"},{"key":"42","unstructured":"42) Anagnostopoulos I, Hummel M, Kreschel C, Stein H. Morphology, immunophenotype, and distribution of latently and\/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 85(3): 744-750,1995"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98(6): 1882-1888.,2001","DOI":"10.1182\/blood.V98.6.1882"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Hudnall SD, Ge Y, Wei L, Yang NP, Wang HQ, Chen T. Distribution and phenotype of Epstein-Barr virus-infected cells in human pharyngeal tonsils. Mod Pathol 18(4): 519-527,2005","DOI":"10.1038\/modpathol.3800369"},{"key":"45","unstructured":"45) Fujiwara S, Ono Y. Isolation of Epstein-Barr virus-infected clones of the human T-cell line MT-2: use of recombinant viruses with a positive selection marker. J Virol 69(6): 3900-3903,1995"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Isobe Y, Sugimoto K, Yang L, Tamayose K, Egashira M, Kaneko T, Takada K, Oshimi K. Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells. Cancer Res 64(6): 2167-2174,2004","DOI":"10.1158\/0008-5472.CAN-03-1562"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Tabiasco J, Vercellone A, Meggetto F, Hudrisier D, Brousset P, Fournie JJ. Acquisition of viral receptor by NK cells through immunological synapse. J Immunol 170(12): 5993-5998,2003","DOI":"10.4049\/jimmunol.170.12.5993"},{"key":"48","unstructured":"48) Takahashi E, Asano N, Li C, Tanaka T, Shimada K, Shimada S, Yoshino T, Kojima M, Hara K, Eimoto T, Nakamura S. Nodal T\/NK-cell lymphoma of nasal type: a clinicopathological study of six cases. Histopathology 52(5): 585-596,2008"},{"key":"49","unstructured":"49) Quintanilla-Martinez L, Kimura H, Jaffe ES. EBV+ T-cell lymphoma of childhood. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. (eds). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn. WHO Press: Lyon, 2008, pp 278-280."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Kanegane H, Wado T, Nunogami K, Seki H, Taniguchi N, Tosato G. Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion. Br J Haematol 95(1): 116-122,1996","DOI":"10.1046\/j.1365-2141.1996.7532375.x"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Toyabe S, Harada W, Uchiyama M. Biclonal expansion of T cells infected with monoclonal Epstein-Barr virus (EBV) in a patient with chronic, active EBV infection. Clin Exp Immunol 134(1): 92-97,2003","DOI":"10.1046\/j.1365-2249.2003.02270.x"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Endo R, Yoshioka M, Ebihara T, Ishiguro N, Kikuta H, Kobayashi K. Clonal expansion of multiphenotypic Epstein-Barr virus-infected lymphocytes in chronic active Epstein-Barr virus infection. Med Hypotheses 63(4): 582-587,2004","DOI":"10.1016\/j.mehy.2004.03.012"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Ohga S, Ishimura M, Yoshimoto G, Miyamoto T, Takada H, Tanaka T, Ohshima K, Ogawa Y, Imadome K, Abe Y, Akashi K, Hara T. Clonal origin of Epstein-Barr virus (EBV)-infected T\/NK-cell subpopulations in EBV-positive T\/NK-cell lymphoproliferative disorders of childhood. J Clin Virol 51(1): 31-37,2011","DOI":"10.1016\/j.jcv.2011.01.014"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Nakamura M, Iwata S, Kimura H, Tokura Y. Elevated expression of activation-induced cytidine deaminase in T and NK cells from patients with chronic active Epstein-Barr virus infection. Eur J Dermatol 21(5): 780-782,2011","DOI":"10.1684\/ejd.2011.1433"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Muramatsu M, Nagaoka H, Shinkura R, Begum NA, Honjo T. Discovery of activation-induced cytidine deaminase, the engraver of antibody memory. Adv Immunol 94: 1-36,2007","DOI":"10.1016\/S0065-2776(06)94001-2"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Okazaki IM, Hiai H, Kakazu N, Yamada S, Muramatsu M, Kinoshita K, Honjo T. Constitutive expression of AID leads to tumorigenesis. J Exp Med 197(9): 1173-1181,2003","DOI":"10.1084\/jem.20030275"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Fan J, Ma G, Nosaka K, Tanabe J, Satou Y, Koito A, Wain-Hobson S, Vartanian JP, Matsuoka M. APOBEC3G generates nonsense mutations in human T-cell leukemia virus type 1 proviral genomes in vivo. J Virol 84(14): 7278-7287,2010","DOI":"10.1128\/JVI.02239-09"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Nakamura M, Sugita K, Sawada Y, Yoshiki R, Hino R, Tokura Y. High levels of activation-induced cytidine deaminase expression in adult T-cell leukaemia\/lymphoma. Br J Dermatol 165(2): 437-439,2011","DOI":"10.1111\/j.1365-2133.2011.10342.x"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Wakiguchi H, Fujieda M, Matsumoto K, Ohara Y, Wakiguchi A, Kurashige T. Defective immune response to Epstein-Barr virus in patients with acute lymphocytic leukemia. Acta Paediatr Jpn 31(2): 144-149,1989","DOI":"10.1111\/j.1442-200X.1989.tb01280.x"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Fujieda M, Wakiguchi H, Hisakawa H, Kubota H, Kurashige T. Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T lymphocytes in children with chronic active EBV infection and in their parents. Acta Paediatrica Japonica 35(5): 394-399,1993","DOI":"10.1111\/j.1442-200X.1993.tb03079.x"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Kimura H, Tsuge I, Imai S, Yamamoto M, Kuzushima K, Osato T, Morishima T. Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection. Med Microbiol Immunol 184(2): 63-68,1995","DOI":"10.1007\/BF00221388"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection. J Med Virol 64(2): 141-148.,2001","DOI":"10.1002\/jmv.1029"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Kuzushima K, Hayashi N, Kudoh A, Akatsuka Y, Tsujimura K, Morishima Y, Tsurumi T. Tetramer-assisted identification and characterization of epitopes recognized by HLA A*2402-restricted Epstein-Barr virus-specific CD8+ T cells. Blood 101(4): 1460-1468,2003","DOI":"10.1182\/blood-2002-04-1240"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Sugaya N, Kimura H, Hara S, Hoshino Y, Kojima S, Morishima T, Tsurumi T, Kuzushima K. Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection. J Infect Dis 190(5): 985-988,2004","DOI":"10.1086\/423285"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Ito Y, Shibata-Watanabe Y, Ushijima Y, Kawada J, Nishiyama Y, Kojima S, Kimura H. Oligonucleotide microarray analysis of gene expression profiles followed by real-time reverse-transcriptase polymerase chain reaction assay in chronic active Epstein-Barr virus infection. J Infect Dis 197(5): 663-666,2008","DOI":"10.1086\/527330"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ. Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100(8): 1969-1979,1997","DOI":"10.1172\/JCI119728"},{"key":"67","unstructured":"67) Imashuku S, Teramura T, Tauchi H, Ishida Y, Otoh Y, Sawada M, Tanaka H, Watanabe A, Tabata Y, Morimoto A, Hibi S, Henter JI. Longitudinal follow-up of patients with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Haematologica 89(2): 183-188,2004"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Kawada J, Kimura H, Shibata Y, Hara S, Hoshino Y, Kojima S, Nishikawa K, Morishima T. Evaluation of apoptosis in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. J Med Virol 78(3): 400-407,2006","DOI":"10.1002\/jmv.20553"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Ohga S, Nomura A, Takada H, Ihara K, Kawakami K, Yanai F, Takahata Y, Tanaka T, Kasuga N, Hara T. Epstein-Barr virus (EBV) load and cytokine gene expression in activated T cells of chronic active EBV infection. J Infect Dis 183(1): 1-7.,2001","DOI":"10.1086\/317653"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Hatta K, Morimoto A, Ishii E, Kimura H, Ueda I, Hibi S, Todo S, Sugimoto T, Imashuku S. Association of transforming growth factor-beta1 gene polymorphism in the development of Epstein-Barr virus-related hematologic diseases. Haematologica 92(11): 1470-1474,2007","DOI":"10.3324\/haematol.11147"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Ishihara S, Okada S, Wakiguchi H, Kurashige T, Morishima T, Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatrica 84(11): 1271-1275,1995","DOI":"10.1111\/j.1651-2227.1995.tb13547.x"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Sato Y, Tsuboi T, Mikami T, Kurosawa H, Kanou K, Sugita K, Kimura H, Nagasaka T, Imashyuku S, Eguchi M. Chronic active Epstein-Barr virus infection with dilatation of the Valsalva sinus. Pediatr Int 48(6): 643-645,2006","DOI":"10.1111\/j.1442-200X.2006.02283.x"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Ishihara S, Okada S, Wakiguchi H, Kurashige T, Hirai K, Kawa-Ha K. Clonal lymphoproliferation following chronic active Epstein-Barr virus infection and hypersensitivity to mosquito bites. Am J Hematol 54(4): 276-281,1997","DOI":"10.1002\/(SICI)1096-8652(199704)54:4<276::AID-AJH3>3.0.CO;2-S"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Tokura Y, Ishihara S, Ohshima K, Hidano A, Koide M, Seo N, Takigawa M. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption. Br J Dermatol 138(5): 905-906,1998","DOI":"10.1046\/j.1365-2133.1998.02236.x"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Asada H, Saito-Katsuragi M, Niizeki H, Yoshioka A, Suguri S, Isonokami M, Aoki T, Ishihara S, Tokura Y, Iwatsuki K, Miyagawa S. Mosquito salivary gland extracts induce EBV-infected NK cell oncogenesis via CD4 T cells in patients with hypersensitivity to mosquito bites. J Invest Dermatol 125(5): 956-961,2005","DOI":"10.1111\/j.0022-202X.2005.23915.x"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Kimura H, Miyake K, Yamauchi Y, Nishiyama K, Iwata S, Iwatsuki K, Gotoh K, Kojima S, Ito Y, Nishiyama Y. Identification of Epstein-Barr virus (EBV)-infected lymphocyte subtypes by flow cytometric in situ hybridization in EBV-associated lymphoproliferative diseases. J Infect Dis 200(7): 1078-1087,2009","DOI":"10.1086\/605610"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Iwatsuki K, Xu Z, Takata M, Iguchi M, Ohtsuka M, Akiba H, Mitsuhashi Y, Takenoshita H, Sugiuchi R, Tagami H, Kaneko F. The association of latent Epstein-Barr virus infection with hydroa vacciniforme. Br J Dermatol 140(4): 715-721,1999","DOI":"10.1046\/j.1365-2133.1999.02777.x"},{"key":"78","unstructured":"78) Barrionuevo C, Anderson VM, Zevallos-Giampietri E, Zaharia M, Misad O, Bravo F, Caceres H, Taxa L, Martinez MT, Wachtel A, Piris MA. Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru. Appl Immunohistochem Mol Morphol 10(1): 7-14,2002"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Chen HH, Hsiao CH, Chiu HC. Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphoma. Br J Dermatol 147(3): 587-591,2002","DOI":"10.1046\/j.1365-2133.2002.04862.x"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Iwatsuki K, Satoh M, Yamamoto T, Oono T, Morizane S, Ohtsuka M, Xu ZG, Suzuki D, Tsuji K. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders. Arch Dermatol 142(5): 587-595,2006","DOI":"10.1001\/archderm.142.5.587"},{"key":"81","unstructured":"81) Nitta Y, Iwatsuki K, Kimura H, Kojima S, Morishima T, Tsuji K, Oono T. Fatal natural killer cell lymphoma arising in a patient with a crop of Epstein-Barr virus-associated disorders. Eur J Dermatol 15(6): 503-506, 2005"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37(1): 132-136,1999","DOI":"10.1128\/JCM.37.1.132-136.1999"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S. Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 80(1): 64-69,2005","DOI":"10.1002\/ajh.20398"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84) Iwata S, Yano S, Ito Y, Ushijima Y, Gotoh K, Kawada JI, Fujiwara S, Sugimoto K, Isobe Y, Nishiyama Y, Kimura H. Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of epstein-barr virus infection. Int J Cancer 129: 2263-2273,2011","DOI":"10.1002\/ijc.25873"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85) Ito Y, Kawabe S, Kojima S, Nakamura F, Nishiyama Y, Kaneko K, Kiuchi T, Ando H, Kimura H. Identification of Epstein-Barr virus-infected CD27+ memory B-cells in liver or stem cell transplant patients. J Gen Virol 92(Pt 11): 2590-2595,2011","DOI":"10.1099\/vir.0.033712-0"},{"key":"86"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87) Kimura H, Morita M, Tsuge I, Hoshino Y, Tanaka N, Ito Y, Morishima T. Vidarabine therapy for severe chronic active Epstein-Barr virus infection. J Pediatr Hematol Oncol 23(5): 294-299.,2001","DOI":"10.1097\/00043426-200106000-00012"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88) Kawa-Ha K, Franco E, Doi S, Yumura K, Ishihara S, Tawa A, Yabuuchi H. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet 1(8525): 154,1987","DOI":"10.1016\/S0140-6736(87)91980-5"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89) Savoldo B, Huls MH, Liu Z, Okamura T, Volk HD, Reinke P, Sabat R, Babel N, Jones JF, Webster-Cyriaque J, Gee AP, Brenner MK, Heslop HE, Rooney CM. Autologous Epstein-Barr virus (EBV)-specific cytotoxic T cells for the treatment of persistent active EBV infection. Blood 100(12): 4059-4066,2002","DOI":"10.1182\/blood-2002-01-0039"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90) Kuzushima K, Yamamoto M, Kimura H, Ando Y, Kudo T, Tsuge I, Morishima T. Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection. Clin Exp Immunol 103 (2): 192-198,1996","DOI":"10.1046\/j.1365-2249.1996.d01-619.x"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91) Wang Q, Liu H, Zhang X, Liu Q, Xing Y, Zhou X, Tong C, Zhu P. High doses of mother's lymphocyte infusion to treat EBV-positive T-cell lymphoproliferative disorders in childhood. Blood 116(26): 5941-5947,2010","DOI":"10.1182\/blood-2010-01-262311"},{"key":"92","unstructured":"92) Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 48(2): 124-131,2007"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93) Kawa K, Sawada A, Sato M, Okamura T, Sakata N, Kondo O, Kimoto T, Yamada K, Tokimasa S, Yasui M, Inoue M. Excellent outcome of allogeneic hematopoietic SCT with reduced-intensity conditioning for the treatment of chronic active EBV infection. Bone Marrow Transplant 46(1): 77-83,2011","DOI":"10.1038\/bmt.2010.122"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94) Okamura T, Hatsukawa Y, Arai H, Inoue M, Kawa K. Blood stem-cell transplantation for chronic active Epstein-Barr virus with lymphoproliferation. Lancet 356(9225): 223-224,2000","DOI":"10.1016\/S0140-6736(00)02488-0"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95) Sato E, Ohga S, Kuroda H, Yoshiba F, Nishimura M, Nagasawa M, Inoue M, Kawa K. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease in Japan. Am J Hematol 83(9): 721-727,2008","DOI":"10.1002\/ajh.21247"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96) Gotoh K, Ito Y, Shibata-Watanabe Y, Kawada J, Takahashi Y, Yagasaki H, Kojima S, Nishiyama Y, Kimura H. Clinical and virological characteristics of 15 patients with chronic active Epstein-Barr virus infection treated with hematopoietic stem cell transplantation. Clin Infect Dis 46(10): 1525-1534,2008","DOI":"10.1086\/587671"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97) Uehara T, Nakaseko C, Hara S, Harima A, Ejiri M, Yokota A, Saito Y, Nishimura M. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection. Am J Hematol 76(4): 368-372,2004","DOI":"10.1002\/ajh.20121"},{"key":"98","unstructured":"98) Iwata S, Saito T, Ito Y, Kamakura M, Gotoh K, Kawada J, Nishiyama Y, Kimura H. Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells. Cancer Sci, in press"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99) Takahashi E, Ohshima K, Kimura H, Hara K, Suzuki R, Kawa K, Eimoto T, Nakamura S. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)\/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders. Histopathology 59(4): 660-671,2011","DOI":"10.1111\/j.1365-2559.2011.03976.x"},{"key":"100","unstructured":"100) Kimura H, Ito Y, Kawabe S, Gotoh K, Takahashi Y, Kojima S, Naoe T, Esaki S, Kikuta A, Sawada A, Kawa K, Ohshima K, Nakamura S. Epstein-Barr virus (EBV)-associated T\/NK lymphoproliferative diseases in non-immunocompromised hosts: prospective analysis of 108 cases. Blood in press"}],"container-title":["Uirusu"],"original-title":["\u6162\u6027\u6d3b\u52d5\u6027EBV\u611f\u67d3\u75c7"],"language":"en","deposited":{"date-parts":[[2021,5,20]],"date-time":"2021-05-20T13:41:02Z","timestamp":1621518062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/61\/2\/61_163\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.61.163","relation":{},"ISSN":["0042-6857"],"issn-type":[{"value":"0042-6857","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}